We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 9,000...
-- STAR-0215 Dosed Once or Twice Over 6 Months Reduced Monthly Attack Rates by 90-96%, Supporting Chronic Dosing 2 or 4 Times Per Year -- -- 92-100% Decrease in Moderate or Severe Attacks and...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...
-- ALPHA-STAR Trial of STAR-0215 Initial Proof-of-Concept Data in HAE Patients Expected Q1 2024 -- -- STAR-0310, Potential Best-in-Class OX40 Program for the Treatment of Atopic Dermatitis, on...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.83 | 9.07103825137 | 9.15 | 10.045 | 9.01 | 1041118 | 9.4744446 | CS |
| 4 | -1.37 | -12.0704845815 | 11.35 | 11.73 | 8.77 | 885830 | 9.91751233 | CS |
| 12 | -4.52 | -31.1724137931 | 14.5 | 16.9 | 8.77 | 1053796 | 13.11017682 | CS |
| 26 | 5.12 | 105.349794239 | 4.86 | 16.9 | 4.26 | 838582 | 11.27489778 | CS |
| 52 | -2.8 | -21.9092331768 | 12.78 | 16.9 | 4.26 | 525578 | 10.73029568 | CS |
| 156 | 1.45 | 16.9988276671 | 8.53 | 16.9 | 2.36 | 272965 | 10.42880222 | CS |
| 260 | 1.45 | 16.9988276671 | 8.53 | 16.9 | 2.36 | 272965 | 10.42880222 | CS |
Monksdream
2 days ago
GreenStockEVs
10 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
